NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
ID: 353057Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $250K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering the Director's Early Independence Awards (DP5 Clinical Trial Optional), a federal grant aimed at supporting promising junior investigators who wish to pursue independent research immediately after completing their doctoral degree or post-graduate clinical training. This initiative encourages applications from a diverse range of eligible institutions and backgrounds, particularly those from underrepresented groups, to foster innovative research across various fields, including behavioral, biomedical, and social sciences. Grants of up to $250,000 per year are available for a maximum of five years, with applications due by September 6, 2024. For further details, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the official announcement at NIH Grants.

    Point(s) of Contact
    Files
    Title
    Posted
    The NIH Director's Early Independence Awards, part of the NIH Common Fund, aims to support exceptional newly graduated researchers who can pursue independent research careers immediately after their doctoral degree or clinical training, bypassing the traditional post-doc phase. This funding opportunity encourages diverse applicants, particularly from underrepresented backgrounds, to propose innovative research spanning behavioral, biomedical, and social sciences. The program provides grants of up to $250,000 per year for a maximum of five years, contingent on availability of funds. Application deadlines, instruction details, and eligibility criteria are specified, with emphasis on institutional support for candidates. Review criteria focus on the investigator's qualifications, innovation of the proposed research, and the supportive environment provided by the host institution. A pre-application webinar is scheduled to assist potential applicants with the submission process, highlighting the NIH's commitment to fostering a diverse and productive research workforce. The initiative seeks to catalyze high-risk, high-reward research with substantial scientific impact on healthcare and related fields.
    Similar Opportunities
    NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Pathway to Independence Award (K99/R00), a federal grant aimed at supporting postdoctoral researchers in their transition to independent faculty positions. This program is designed to provide up to five years of funding, divided into two phases: the K99 phase for mentored training and the R00 phase for independent research, specifically targeting individuals with no more than four years of postdoctoral experience. The initiative emphasizes the importance of cultivating a diverse and skilled workforce in biomedical and clinical research, encouraging applications from underrepresented groups. Interested applicants must submit their proposals by May 7, 2027, and can find additional information and application guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Directors Pioneer Award Program (DP1 Clinical Trial Optional), aimed at funding innovative and high-impact research proposals from individual scientists demonstrating exceptional creativity. This program encourages applications from diverse backgrounds, particularly those from underrepresented groups, to propose groundbreaking research that significantly diverges from their current work. With a total funding target of approximately $8 million across seven awards, each award can provide up to $700,000 annually for five years, with applications due by September 9, 2024. Interested applicants should ensure compliance with detailed submission guidelines and complete all necessary registrations in advance, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00), aimed at facilitating the transition of postdoctoral fellows to independent faculty positions. This program is specifically designed for researchers with clinical or research doctoral degrees who require minimal additional mentored training and are proposing to lead independent clinical trials or studies. The award consists of two phases: the K99 phase provides up to $100,000 annually for two years of mentored research, followed by the R00 phase, which offers up to $249,000 per year for three years of independent research. Interested applicants must adhere to detailed submission guidelines and can find more information at the provided NIH link. The application deadline is October 14, 2026, and inquiries can be directed to grantsinfo@nih.gov.
    NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Pathway to Independence Award (K99/R00), a federal grant aimed at supporting exceptional postdoctoral researchers in their transition to independent faculty positions while conducting basic experimental studies involving human subjects. This program is designed to facilitate a timely shift from mentored postdoctoral roles to independent research careers, providing funding for up to five years, divided into a mentored K99 phase (up to two years) and an independent R00 phase (up to three years), contingent upon successful transition to tenure-track or equivalent positions. Eligible applicants include a diverse range of institutions, such as Historically Black Colleges and Universities and Tribal Colleges, with key application deadlines starting May 10, 2024, and the final submission date set for May 7, 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the program's webpage for additional details.
    NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIAID New Innovators Awards (DP2), a federal grant aimed at supporting exceptionally creative postdoctoral and early-stage investigators in biomedical research. This funding opportunity encourages innovative research proposals that challenge existing paradigms and may lead to significant advances in the fields of infectious, immunologic, and allergic diseases. Eligible applicants can request up to $300,000 in direct costs per year for a maximum of five years, with the application period open from September 13, 2023, to October 11, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-198.html.
    NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00), aimed at facilitating the transition of postdoctoral fellows into independent faculty positions in cancer research. This grant program is designed for researchers with doctoral degrees who require minimal additional mentored training, providing up to two years of support during the K99 phase followed by up to three years of independent research funding in the R00 phase. The initiative underscores NIH's commitment to strengthening the workforce in cancer research, particularly in areas such as cancer control and prevention, while ensuring that applicants present a comprehensive career development plan and mentorship strategy. Applications will open on January 14, 2024, with potential awards beginning in February 2024; interested parties can contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIAID Physician-Scientist Pathway to Independence Award (K99/R00), a federal grant aimed at supporting the transition of outstanding postdoctoral researchers with clinical doctorate degrees into independent research positions. This program seeks to address the national shortage of physician-scientists by providing a structured pathway that includes up to two years of mentored training followed by up to two years of independent research funding, contingent upon securing a tenure-track position. Eligible applicants include a diverse range of institutions such as higher education institutions, nonprofits, and certain health organizations, with applications evaluated based on the candidate's potential, career development plan, and the scientific merit of the proposed research. Interested parties should note that the application deadline is January 7, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-071.html.
    Independent Scientist Award (Parent K02 - Independent Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Independent Scientist Award (Parent K02 - Independent Clinical Trial Required), a federal grant aimed at supporting newly independent research scientists in their pursuit of intensive research over a period of three to five years. This funding opportunity is specifically designed for applicants who will serve as lead investigators in independent clinical trials or related studies involving human participants, thereby enhancing their research careers and contributions to health-related fields. Eligible applicants must possess a doctoral degree, demonstrate independent peer-reviewed research support, and commit at least 75% of their professional effort to research activities. The application deadline is May 7, 2027, and interested parties can find more information and contact NIH Grants Information at grantsinfo@nih.gov or visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PA-24-178.html.
    Independent Scientist Award (Parent K02 - Independent Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Independent Scientist Award (K02), a federal grant designed to support newly independent scientists in advancing their research careers. This award provides three to five years of salary support and "protected time" for candidates who demonstrate the need for focused research, specifically excluding those leading independent clinical trials. The initiative aims to foster significant contributions to biomedical, behavioral, and clinical research, encouraging applications from diverse backgrounds, including historically underrepresented institutions. Interested applicants must adhere to specific guidelines and submit their applications by May 7, 2027, with further details available at the NIH Grants Information website or by contacting grantsinfo@nih.gov.
    Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Independent Scientist Award (K02), a federal grant aimed at supporting outstanding scientists through salary support and "protected time" for intensive research over a period of three to five years. This opportunity is specifically designed for independent researchers conducting basic science experimental studies involving human subjects, which must align with the scientific missions of various NIH Institutes and Centers. The K02 award is crucial for fostering diversity in biomedical research and advancing scientific fields by enabling researchers to explore fundamental phenomena without immediate product applications in mind. Interested applicants must hold a doctoral degree, demonstrate independent research support, and commit at least 75% of their professional effort to research. The application submission opens on May 13, 2024, with a close date of May 7, 2027. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PA-24-180.html.